317 related articles for article (PubMed ID: 6231096)
1. Immunology of metastasis. Can the immune response cope with disseminated tumor?
Frost P; Kerbel RS
Cancer Metastasis Rev; 1983; 2(3):239-56. PubMed ID: 6231096
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the antitumor immune response.
North RJ
Adv Cancer Res; 1985; 45():1-43. PubMed ID: 2936064
[No Abstract] [Full Text] [Related]
3. Tumor resistance to CD8+ T cell-based therapeutic vaccination.
Huang Y; Shah S; Qiao L
Arch Immunol Ther Exp (Warsz); 2007; 55(4):205-17. PubMed ID: 17659376
[TBL] [Abstract][Full Text] [Related]
4. Roles of regulatory T cells in cancer immunity.
Takeuchi Y; Nishikawa H
Int Immunol; 2016 Aug; 28(8):401-9. PubMed ID: 27160722
[TBL] [Abstract][Full Text] [Related]
5. Immune checkpoint inhibitors with radiotherapy and locoregional treatment: synergism and potential clinical implications.
Esposito A; Criscitiello C; Curigliano G
Curr Opin Oncol; 2015 Nov; 27(6):445-51. PubMed ID: 26447875
[TBL] [Abstract][Full Text] [Related]
6. Immunology in tumor therapeutics: an overview.
Barber HR
Del Med J; 1980 Apr; 52(4):197-209. PubMed ID: 6153996
[No Abstract] [Full Text] [Related]
7. Tumor immunology.
Shu S; Plautz GE; Krauss JC; Chang AE
JAMA; 1997 Dec; 278(22):1972-81. PubMed ID: 9396660
[TBL] [Abstract][Full Text] [Related]
8. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
Rolinski J; Hus I
J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of immune escape of cancer and its regulation.
Morita R; Hirohashi Y; Torigoe T
Rinsho Ketsueki; 2009 May; 50(5):375-80. PubMed ID: 19483397
[No Abstract] [Full Text] [Related]
10. Suppressor mechanisms in tumor immunity.
Nepom GT; Hellström I; Hellström KE
Experientia; 1983 Mar; 39(3):235-42. PubMed ID: 6186519
[TBL] [Abstract][Full Text] [Related]
11. Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.
Toes RE; Offringa R; Feltkamp MC; Visseren MJ; Schoenberger SP; Melief CJ; Kast WM
Behring Inst Mitt; 1994 Jul; (94):72-86. PubMed ID: 7998917
[TBL] [Abstract][Full Text] [Related]
12. [Cytotoxic T-lymphocytes and the recognition of tumor antigens--an approach to "preventive tumor vaccination?"].
Peiper M; Goedegebuure PS; Eberlein TJ; Zornig C
Zentralbl Chir; 1997; 122(3):141-8. PubMed ID: 9206906
[TBL] [Abstract][Full Text] [Related]
13. An introduction to tumour immunology.
Keith J
Mater Med Pol; 1984; 16(1):54-64. PubMed ID: 6394909
[No Abstract] [Full Text] [Related]
14. [T Lymphocytes with Modified Specificity in the Therapy of Malignant Diseases].
Vdovin AS; Bykova NA; Efimov GA
Mol Biol (Mosk); 2017; 51(6):1008-1023. PubMed ID: 29271964
[TBL] [Abstract][Full Text] [Related]
15. Tumor antigen targets and tumor immunotherapy.
Mufson RA
Front Biosci; 2006 Jan; 11():337-43. PubMed ID: 16146735
[TBL] [Abstract][Full Text] [Related]
16. Recognition of tumor-associated antigens by T lymphocytes: from basic concepts to new approaches.
Cerottini JC; von Fliedner V; Boon T
Ann Oncol; 1992 Jan; 3(1):11-6. PubMed ID: 1606063
[No Abstract] [Full Text] [Related]
17. Tumor immunology: present perspectives.
Klein G; Boon T
Curr Opin Immunol; 1993 Oct; 5(5):687-92. PubMed ID: 8240730
[No Abstract] [Full Text] [Related]
18. Metastatic spread and "escape" from the immune defenses of the host.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside.
Braza MS; Klein B
Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882
[TBL] [Abstract][Full Text] [Related]
20. Tumor immunology--three decades in review.
Brodt P
Annu Rev Microbiol; 1983; 37():447-76. PubMed ID: 6227278
[No Abstract] [Full Text] [Related]
[Next] [New Search]